Systemic Lupus Erythematosus
A multisystem autoimmune disease in which loss of tolerance to nuclear antigens generates immune complexes that deposit wherever they lodge, igniting complement-driven inflammation in the skin, joints, kidneys, serosa and brain alike.
First principles
SLE begins with a failure to clear the body's own nuclear debris
Cells die constantly through normal turnover, releasing nuclear material (DNA, histones, ribonucleoproteins) that is usually cleared efficiently. In genetically susceptible individuals, often triggered by factors such as UV light, infection, hormonal influences or certain drugs, this clearance is impaired, and the persisting nuclear antigens are presented to B and T cells that have failed to maintain tolerance to self. The result is production of autoantibodies directed against nuclear components: the antinuclear antibody (ANA) response that is the serological hallmark of the disease and the starting point of everything that follows.
Educational content pending clinical review. Not medical advice.